Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Dongsheng Pharmaceutical is a comprehensive pharmaceutical enterprise based in Xianning, China, specializing in the research, development, and large-scale manufacturing of Traditional Chinese Medicine (TCM) and modern chemical drugs. The company operates advanced, GMP-certified production lines for various dosage forms, including capsules, tablets, and granules. Its product portfolio is primarily focused on therapeutic areas such as cardiovascular health, hepatology, nephrology, and respiratory ailments. Recognized for its proprietary "Dongsheng" brand, the company plays a significant role in the regional pharmaceutical supply chain in Hubei Province. Hubei Dongsheng Pharmaceutical integrates traditional herbal wisdom with modern pharmaceutical technology to serve the domestic Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Dongsheng Pharmaceutical.